Celldex Therapeutics buy TD Cowen
Start price
20.12.23
/
50%
€35.40
Target price
20.12.24
-
Performance (%)
-34.46%
End price
21.12.24
€23.20
Summary
This prediction ended on 21.12.24 with a price of €23.20. Massive losses of -34.46% were the result for the BUY prediction by TD_Cowen. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | -4.762% | -4.762% | -5.512% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by TD_Cowen for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten